Published guidance, NICE advice and quality standards

Showing 611 to 620 of 757

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation	TA311	23 April 2014	23 April 2014
Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis	TA308	26 March 2014	26 March 2014
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy	TA307	25 March 2014	25 March 2014
Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip	TA304	26 February 2014	26 February 2014
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	26 February 2014	26 February 2014
Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma	TA306	26 February 2014	26 February 2014
Ranibizumab for treating choroidal neovascularisation associated with pathological myopia	TA298	27 November 2013	27 November 2013
Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people	TA300	27 November 2013	27 November 2013
Canakinumab for treating systemic juvenile idiopathic arthritis (terminated appraisal)	TA302	27 November 2013	27 November 2013
Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C	TA106	23 August 2006	1 November 2013